Literature DB >> 25268016

The Effectiveness of the Personality Assessment Inventory With Feigned PTSD: An Initial Investigation of Resnick's Model of Malingering.

Chelsea N Wooley1, Richard Rogers2.   

Abstract

Malingered posttraumatic stress disorder (PTSD) poses a formidable clinical challenge because of the apparent ease in feigning PTSD. As an additional confound, some patients with genuine PTSD produce elevated profiles on feigning indicators that are difficult to distinguish from feigned PTSD. The current study utilized 109 inpatients from a trauma unit to examine whether the Personality Assessment Inventory and the Detailed Assessment of Posttraumatic Stress can effectively differentiate between genuine and feigned PTSD. As a primary focus, Resnick's model of malingered PTSD was evaluated with its three subtypes: pure malingering, partial malingering, and false imputation. They were tested on their ability to (a) effectively simulate PTSD and (b) avoid being classified as feigning. The partial malingering group proved to be the best feigning group in achieving these two goals. Overall, the Personality Assessment Inventory Malingering Index and Negative Distortion Scale were the most effective at identifying feigning.
© The Author(s) 2014.

Entities:  

Keywords:  DAPS; PAI; PTSD; Personality Assessment Inventory; feigning; malingering

Mesh:

Year:  2014        PMID: 25268016     DOI: 10.1177/1073191114552076

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  2 in total

Review 1.  Civil Forensic Evaluation in Psychological Injury and Law: Legal, Professional, and Ethical Considerations.

Authors:  William E Foote; Jane Goodman-Delahunty; Gerald Young
Journal:  Psychol Inj Law       Date:  2020-11-24

Review 2.  DSM-5 Criteria and Its Implications for Diagnosing PTSD in Military Service Members and Veterans.

Authors:  Jeffrey Guina; Randon S Welton; Pamela J Broderick; Terry L Correll; Ryan P Peirson
Journal:  Curr Psychiatry Rep       Date:  2016-05       Impact factor: 5.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.